Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sadatsafavi, P. Bedouch, M. FitzGerald, C. Narra, L. Lynd (Vancouver, Canada). Stepping up the controller medication in asthma patients: Impact of various treatment options on costs. Eur Respir J 2011; 38: Suppl. 55, 4681

Member's Comments

No comment yet.

Related content which might interest you: Initiation of controller medication in newly diagnosed asthma patients: Impact on economic resource utilization Source: Annual Congress 2011 - New insights in the incidence, variation and risk factors of asthma Year: 2011 Impact of add-on medications on patient‘s satisfaction in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 273s Year: 2005 Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Adherence to asthma medication and preferences for once-daily treatment: Importance of treatment intrusiveness and patient beliefs Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 In whom should regular asthma controller therapy be initiated? Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Real-life asthma impairment: SABA use depends on smoking phenotype Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Modelling cost effectiveness of a COPD pathway using the Star approach; could cognitive behavioural therapy (CBT) be cost effective in preventing panic-associated admissions? Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Symptom pattern and treatment for people non-compliant with asthma medication Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care Year: 2005 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Improving adherence to asthma medications: same-old, same-old? Source: Eur Respir J, 57 (6) 2004284; 10.1183/13993003.04284-2020 Year: 2021 Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Rescue/acute and allergy medication use among children on asthma controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004 Impact of home hospitalization on treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001